top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjournal

Despite the current lack of redox biomarkers in clinical application, the integral role of reactive oxygen species (ROS) in the pathogenesis of cardiovascular disease provides a strong incentive for ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 01/07/2015 Item size : 207247 bytes
Ehjournal

Furthermore, the EMPA-REG OUTCOME trial using the novel antihyperglycaemic agent, empagliflozin,8 a selective sodiumglucose co- transporter inhibitor, significantly reduced cardiovascular mortality; ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 07/02/2016